In alcoholic liver disease (ALD), Tarangabin regulates the expression levels of tumor necrosis factor (TNF)-α and toll-like receptor 4 (TLR4) mRNA by acting on the lipopolysaccharide-TLR (LPS-TLR) signaling pathway, thereby improving the severity of ALD. The gene discussed is TNF; the disease is alcoholic liver diseases.